Carbohydrate Counting/Bolus Calculator Mobile Application Improves Time in Range in Adults with Type 1 Diabetes Subjects.

IF 6.3 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Sara A AlBabtain, Nora O AlAfif, Mohammed S Almehthel, Anwar A Jammah, Tariq A Wani, Tarfa A Aldahham, Ramzi A Ajjan, Saad H AlZahrani
{"title":"Carbohydrate Counting/Bolus Calculator Mobile Application Improves Time in Range in Adults with Type 1 Diabetes Subjects.","authors":"Sara A AlBabtain, Nora O AlAfif, Mohammed S Almehthel, Anwar A Jammah, Tariq A Wani, Tarfa A Aldahham, Ramzi A Ajjan, Saad H AlZahrani","doi":"10.1177/15209156251376012","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Objective:</i></b> To evaluate the effectiveness and safety of a mobile application for carbohydrate counting and bolus calculation (CHOC-BC) in adults with type 1 diabetes mellitus (T1DM). <b><i>Research Design and Methods:</i></b> A 12-week randomized controlled trial was conducted at King Fahad Medical City, Riyadh, Saudi Arabia. Adults with T1DM on multiple daily insulin injections and using Libre 2 glucose monitors were randomized to either CHOC-BC or conventional treatment. The primary endpoint was time in range (TIR; 70-180 mg/dL). <b><i>Results:</i></b> A total of 127 participants (70 females) were included: 64 in the intervention group and 63 in the control group with a mean age of 26.56 ± 4.8 and 26.74 ± 6.52 years, respectively. After 3 months, the intervention group achieved better TIR than the control group (51.20% ± 11.61% vs. 46.17% ± 13.02%; mean difference [MD], 5.03; 95% confidence interval [CI], 0.70-9.36; <i>P</i> = 0.023). Application users showed a significant reduction in level 2 time above range (17.25% ± 11.61% vs. 24.10% ± 15.74%; MD, -6.85; 95% CI, -11.70 to -1.99; <i>P</i> = 0.006). No significant differences were observed in body weight or time below range. <b><i>Conclusions:</i></b> The CHOC-BC mobile application empowered users to achieve better glycemic control while maintaining a safe profile that avoids hypoglycemia and weight gain.</p>","PeriodicalId":11159,"journal":{"name":"Diabetes technology & therapeutics","volume":" ","pages":""},"PeriodicalIF":6.3000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes technology & therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15209156251376012","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To evaluate the effectiveness and safety of a mobile application for carbohydrate counting and bolus calculation (CHOC-BC) in adults with type 1 diabetes mellitus (T1DM). Research Design and Methods: A 12-week randomized controlled trial was conducted at King Fahad Medical City, Riyadh, Saudi Arabia. Adults with T1DM on multiple daily insulin injections and using Libre 2 glucose monitors were randomized to either CHOC-BC or conventional treatment. The primary endpoint was time in range (TIR; 70-180 mg/dL). Results: A total of 127 participants (70 females) were included: 64 in the intervention group and 63 in the control group with a mean age of 26.56 ± 4.8 and 26.74 ± 6.52 years, respectively. After 3 months, the intervention group achieved better TIR than the control group (51.20% ± 11.61% vs. 46.17% ± 13.02%; mean difference [MD], 5.03; 95% confidence interval [CI], 0.70-9.36; P = 0.023). Application users showed a significant reduction in level 2 time above range (17.25% ± 11.61% vs. 24.10% ± 15.74%; MD, -6.85; 95% CI, -11.70 to -1.99; P = 0.006). No significant differences were observed in body weight or time below range. Conclusions: The CHOC-BC mobile application empowered users to achieve better glycemic control while maintaining a safe profile that avoids hypoglycemia and weight gain.

碳水化合物计数/丸剂计算器移动应用程序改善成人1型糖尿病患者的范围时间。
目的:评价1型糖尿病(T1DM)患者碳水化合物计数和丸量计算(chocc - bc)移动应用程序的有效性和安全性。研究设计与方法:在沙特阿拉伯利雅得法赫德国王医疗城进行了一项为期12周的随机对照试验。每天多次注射胰岛素并使用Libre 2型血糖监测仪的T1DM患者被随机分配到chocc - bc或常规治疗组。主要终点是时间范围(TIR; 70-180 mg/dL)。结果:共纳入受试者127例,其中女性70例,干预组64例,对照组63例,平均年龄分别为26.56±4.8岁和26.74±6.52岁。3个月后,干预组TIR优于对照组(51.20%±11.61%∶46.17%±13.02%;平均差值[MD] 5.03; 95%可信区间[CI] 0.70 ~ 9.36; P = 0.023)。应用程序使用者在2级以上时间范围内显着减少(17.25%±11.61% vs. 24.10%±15.74%;MD, -6.85; 95% CI, -11.70至-1.99;P = 0.006)。在体重或低于范围的时间方面没有观察到显著差异。结论:chocc - bc移动应用程序使用户能够更好地控制血糖,同时保持安全的状态,避免低血糖和体重增加。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes technology & therapeutics
Diabetes technology & therapeutics 医学-内分泌学与代谢
CiteScore
10.60
自引率
14.80%
发文量
145
审稿时长
3-8 weeks
期刊介绍: Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信